Evidence map›Paper›PMID 32246263›Full record

ReviewEuropean journal of nutrition2020

Considerations for the design and conduct of human gut microbiota intervention studies relating to foods.

J R Swann, M Rajilic-Stojanovic, A Salonen, O Sakwinska, C Gill, A Meynier, P Fança-Berthon, B Schelkle, N Segata, C Shortt and 2 more

Abstract readReview
In one paragraph

Review in European journal of nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Gut health, the microbiome and dietary choices: An exploration of consumer perspectives.Nutrition & dietetics : the journal of the Dietitians Association of Australia · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

J R SwannDivision of Integrative Systems Medicine and Digestive Diseases, Imperial College London, London, UK.
M Rajilic-StojanovicDepartment for Biochemical Engineering and Biotechnology, Faculty of Technology and Metallurgy, University of Belgrade, Belgrade, Serbia.
A SalonenHuman Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
O SakwinskaSociété Des Produits Nestlé S.A, Nestlé Research, Lausanne, Switzerland.
C GillNutrition Innovation Centre for Food and Health, Centre for Molecular Biosciences, Ulster University, Londonderry, Northern Ireland, UK.
A MeynierMondelēz France R&D, Saclay, France.
P Fança-BerthonNaturex SA, Avignon, France.
B SchelkleILSI Europe, Brussels, Belgium. publications@ilsieurope.be.
N SegataDepartment CIBIO, University of Trento, Trento, Italy.
C ShorttJohnson & Johnson Consumer Services EAME Ltd., Foundation Park, Maidenhead, UK.
K TuohyDepartment of Food Quality and Nutrition, Research and Innovation Centre, Fondazione Edmund Mach, Trento, Italy.
O HasselwanderDuPont Nutrition and Biosciences, c/o Danisco (UK) Limited, Reigate, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the growing appreciation for the influence of the intestinal microbiota on human health, there is increasing motivation to design and refine interventions to promote favorable shifts in the microbiota and their interactions with the host. Technological advances have improved our understanding and ability to measure this indigenous population and the impact of such interventions. However, the rapid growth and evolution of the field, as well as the diversity of methods used, parameters measured and populations studied, make it difficult to interpret the significance of the findings and translate their outcomes to the wider population. This can prevent comparisons across studies and hinder the drawing of appropriate conclusions. This review outlines considerations to facilitate the design, implementation and interpretation of human gut microbiota intervention studies relating to foods based upon our current understanding of the intestinal microbiota, its functionality and interactions with the human host. This includes parameters associated with study design, eligibility criteria, statistical considerations, characterization of products and the measurement of compliance. Methodologies and markers to assess compositional and functional changes in the microbiota, following interventions are discussed in addition to approaches to assess changes in microbiota-host interactions and host responses. Last, EU legislative aspects in relation to foods and health claims are presented. While it is appreciated that the field of gastrointestinal microbiology is rapidly evolving, such guidance will assist in the design and interpretation of human gut microbiota interventional studies relating to foods.

Indexed as

Gastrointestinal MicrobiomeMicrobiotaProbioticsFoodGastrointestinal TractHumansPrebioticsPrebioticsFoodsGut bacteriaHuman studiesIntestinal microbesMicrobiomeMicrobiotaPrebioticsProbiotics

Identifiers

PMID32246263
PMCPMC7669793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.